Tibbiyah turns to SAR 23.6M profit in 2025; H2 at SAR 47.9M

30/03/2026 Argaam Exclusive

Content Summary:

Loading data...

Comments Analysis:

Positive: 0%
Neutral: 0%
Negative: 0%
Comments Summary:Loading data...
Please note that this news summary has been generated using artificial intelligence. It is recommended to review the original sources for complete details and to verify the accuracy of the information.

Arabian International Healthcare Holding Co. (Tibbiyah) reported profits of SAR 23.6 million by the end of 2025, against a loss of SAR 66.6 million in 2024.



Financials (Million Riyal)

Item 2024 2025 Change‬
Revenues 739.28 842.21 13.9 %
Gross Income 172.29 194.77 13.0 %
Operating Income 36.42 65.66 80.3 %
Net Income (66.61) 23.60 135.4 %
Average Shares 20.00 20.00 -
Earnings Per Share before unusual items (Riyals) (0.56) 1.18 312.4 %
EPS (Riyal) (3.33) 1.18 135.4 %

Revenue increased 13.9% year-on-year (YoY) in 2025 due to the strong performance of Al Faisaliah Medical Systems (FMS) and the higher revenue contribution from Al-Hammad Medical Services Co.

 

This revenue growth effectively offset the slight decline seen at International Medical Supplies Co. (Premma), leading to a 13% rise in gross income.

 

Meanwhile, the gross profit margin (GPM) stood at 23.1% in 2025, slightly down from 23.3% in 2024.

 

Tibbiyah reported that the profit improvement was supported by the non-recurrence of a SAR 93.7 million brand impairment recorded in 2024, along with a better-than-expected impact of credit losses, reflected in a net reversal provision of SAR 0.2 million in 2025, compared to a SAR 17.5 million impairment provision in 2024.

 

This positive effect was further reinforced by a decline in financing expenses to SAR 36.1 million from SAR 40.5 million in 2024, despite an increase in Zakat expenses to SAR 10.2 million, up from SAR 7.8 million in 2024.

 

Tibbiyah reported a profit of SAR 47.9 million in H2 2025, compared to a loss of SAR 34.8 million in H2 2024 and SAR 24.29 million in H1 2025.



Current Half Annual Comparison (Million Riyal)

Compared With The
Item H2 2024 H2 2025 Change‬
Revenues 465.19 493.36 6.1 %
Gross Income 110.33 115.28 4.5 %
Operating Income 52.90 67.23 27.1 %
Net Income (34.80) 47.89 237.6 %
Average Shares 20.00 20.00 -
Earnings Per Share before unusual items (Riyal) 1.05 2.39 128.1 %
EPS (Riyal) (1.74) 2.39 237.6 %

Total shareholders' equity, no minority interest, reached SAR 365.16 million at the end of 2025, up from SAR 244 million a year before.

 

Attached Documents:
 

View More Financial Results

 

View other reports

Share Price

Arabian International Healthcare Holding Co.
20.50
(0.50) (2.38 %)

Arabian International Healthcare Holding Co. (TIBBIYAH)

More


Financial Ratios
Current
Market Cap (M Riyal) 410.00
Enterprise Value (EV) (M Riyal) 710.73
Shares Outstanding ((M)) 20.00
Recurring EPS ( Riyal) (TTM) 1.18
Book Value (BV) ( Riyal) 18.26
Par Value ( Riyal) 10.00
Recurring P/E (TTM) 17.37
P/E (TTM) 17.37
Price/book 1.12
Return on Average Assets (%) (TTM) 1.8
Return on Average Equity (%) (TTM) 7.7
EV/adj EBITDA 8.52
EV/Revenues 0.84
more

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.

Contact Us (+966)-92000-7759

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Popular Links

Quick Links

Join Us

Argaam.com Copyright © 2026, Argaam Investment, All Rights Reserved
Call Request